# abrdn Life Sciences Investors: Form DEF 14A, filed Apr 12, 2022

- Company: [abrdn Life Sciences Investors](/companies/hql.md) (CIK 884121)
- Form: DEF 14A
- Filed: 2022-04-12
- Accepted by EDGAR: Apr 12, 2022, 18:50 ET
- Period: 2022-06-09
- Accession: 0001104659-22-045017
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/884121/000110465922045017/tm222535d4_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/884121/000110465922045017/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/884121/000110465922045017/tm222535d4_def14a.htm

Filed Apr 12, 2022.
Source: SEC EDGAR, the filing index for accession 0001104659-22-045017. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.